Three key factors predicting the severity of exacerbations of chronic obstructive pulmonary disease: T lymphocytes, lactate, and prealbumin.

IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM
Journal of thoracic disease Pub Date : 2025-04-30 Epub Date: 2025-04-28 DOI:10.21037/jtd-2025-416
Haijun Wang, Peter S P Cho, Vasileios Kouritas, Lanfang Feng
{"title":"Three key factors predicting the severity of exacerbations of chronic obstructive pulmonary disease: T lymphocytes, lactate, and prealbumin.","authors":"Haijun Wang, Peter S P Cho, Vasileios Kouritas, Lanfang Feng","doi":"10.21037/jtd-2025-416","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a significant disease, and the main burden on global human health and economy. Currently, the pulmonary function test is the most common method for diagnosing AECOPD in clinical practice. The three levels (Grade I, II and III) of AECOPD exhibit different clinical characteristics and have a significant impact on the treatment and prognosis of patients. This study examined the correlation between serum lactic acid, pre-albumin, and lymphocyte levels, and the severity of AECOPD.</p><p><strong>Methods: </strong>A total of 261 patients with AECOPD were divided into the following three grades: Grade I: patients without respiratory failure. Grade II: patients with non-life-threatening respiratory failure; and Grade III: patients with life-threatening respiratory failure. The serum markers of the patients were analyzed. Flow cytometry was used to identify T, B, and natural killer (NK) lymphocyte subgroups, while immunoturbidimetry and an enzyme-linked immunosorbent assay (ELISA) were used to detect pre-albumin and lactic acid levels, respectively.</p><p><strong>Results: </strong>Cluster of differentiation (CD)3<sup>+</sup> T cells, CD4<sup>+</sup> T cells, and the CD4<sup>+</sup>/CD8<sup>+</sup> ratio were significantly higher in the Grade I group, while CD19<sup>+</sup> B cells were significantly lower in the Grade II group. The Grade I group also had higher levels of CD56<sup>+</sup> cells than the Grade III group. Serum pre-albumin levels were significantly lower in Grade II and III groups, while serum lactate levels were significantly higher in the Grade III group. C-reactive protein (CRP) levels were also higher in the Grade II group.</p><p><strong>Conclusions: </strong>Serum pre-albumin, lactate, and lymphocyte levels were found to be closely related to the severity of AECOPD, and could be potential biomarkers for clinical diagnosis.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"17 4","pages":"2386-2393"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12090175/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-2025-416","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a significant disease, and the main burden on global human health and economy. Currently, the pulmonary function test is the most common method for diagnosing AECOPD in clinical practice. The three levels (Grade I, II and III) of AECOPD exhibit different clinical characteristics and have a significant impact on the treatment and prognosis of patients. This study examined the correlation between serum lactic acid, pre-albumin, and lymphocyte levels, and the severity of AECOPD.

Methods: A total of 261 patients with AECOPD were divided into the following three grades: Grade I: patients without respiratory failure. Grade II: patients with non-life-threatening respiratory failure; and Grade III: patients with life-threatening respiratory failure. The serum markers of the patients were analyzed. Flow cytometry was used to identify T, B, and natural killer (NK) lymphocyte subgroups, while immunoturbidimetry and an enzyme-linked immunosorbent assay (ELISA) were used to detect pre-albumin and lactic acid levels, respectively.

Results: Cluster of differentiation (CD)3+ T cells, CD4+ T cells, and the CD4+/CD8+ ratio were significantly higher in the Grade I group, while CD19+ B cells were significantly lower in the Grade II group. The Grade I group also had higher levels of CD56+ cells than the Grade III group. Serum pre-albumin levels were significantly lower in Grade II and III groups, while serum lactate levels were significantly higher in the Grade III group. C-reactive protein (CRP) levels were also higher in the Grade II group.

Conclusions: Serum pre-albumin, lactate, and lymphocyte levels were found to be closely related to the severity of AECOPD, and could be potential biomarkers for clinical diagnosis.

预测慢性阻塞性肺疾病恶化严重程度的三个关键因素:T淋巴细胞、乳酸和前白蛋白。
背景:慢性阻塞性肺疾病急性加重(AECOPD)是一种重大疾病,是全球人类健康和经济的主要负担。目前,肺功能检查是临床上诊断AECOPD最常用的方法。AECOPD的三级(I级、II级、III级)表现出不同的临床特征,对患者的治疗和预后有显著影响。本研究检测了血清乳酸、前白蛋白和淋巴细胞水平与AECOPD严重程度之间的相关性。方法:将261例AECOPD患者分为以下3个级别:I级:无呼吸衰竭患者。II级:无危及生命的呼吸衰竭患者;III级:危及生命的呼吸衰竭患者。分析患者的血清标志物。采用流式细胞术鉴定T、B和自然杀伤(NK)淋巴细胞亚群,采用免疫比浊法和酶联免疫吸附试验(ELISA)分别检测前白蛋白和乳酸水平。结果:ⅰ级组cd3 + T细胞、CD4+ T细胞、CD4+/CD8+比值明显增高,ⅱ级组CD19+ B细胞明显降低。I级组的CD56+细胞水平也高于III级组。II级组和III级组血清前白蛋白水平显著降低,III级组血清乳酸水平显著升高。II级组c反应蛋白(CRP)水平也较高。结论:血清前白蛋白、乳酸和淋巴细胞水平与AECOPD的严重程度密切相关,可作为临床诊断的潜在生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of thoracic disease
Journal of thoracic disease RESPIRATORY SYSTEM-
CiteScore
4.60
自引率
4.00%
发文量
254
期刊介绍: The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信